Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 41,651,000 | 40,905,000 | 40,825,000 | 52,546,000 | 52,824,000 |
| Cost of Goods | 8,484,000 | 8,054,000 | 8,987,000 | 11,228,000 | 12,322,000 |
| Gross Profit | 33,167,000 | 32,851,000 | 31,838,000 | 41,318,000 | 40,502,000 |
| Operating Expenses | 24,917,000 | 26,141,000 | 26,166,000 | 27,596,000 | 28,357,000 |
| Operating Income | 8,250,000 | 6,710,000 | 5,672,000 | 13,722,000 | 12,145,000 |
| Other Income | -1,214,000 | 4,611,000 | -2,078,000 | -1,417,000 | -3,794,000 |
| Pre-tax Income | 7,036,000 | 11,321,000 | 3,594,000 | 12,305,000 | 8,351,000 |
| Income Tax | 370,000 | 583,000 | -266,000 | -9,049,000 | 1,123,000 |
| Net Income Continuous | 6,666,000 | 10,738,000 | 3,861,000 | 21,353,000 | 7,229,000 |
| Net Income Discontinuous | 2,529,000 | 5,318,000 | 7,328,000 | 2,000 | 16,000 |
| Minority Interests | 36,000 | 29,000 | 36,000 | 47,000 | 31,000 |
| Net Income | $9,159,000 | $16,027,000 | $11,152,000 | $21,308,000 | $7,215,000 |
| EPS Basic Total Ops | 1.65 | 2.88 | 1.90 | 3.57 | 1.18 |
| EPS Basic Continuous Ops | 1.19 | 1.92 | 0.65 | 3.57 | 1.18 |
| EPS Basic Discontinuous Ops | 0.46 | 0.95 | 1.25 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 1.63 | 2.82 | 1.87 | 3.52 | 1.17 |
| EPS Diluted Continuous Ops | 1.18 | 1.89 | 0.64 | 3.52 | 1.17 |
| EPS Diluted Discontinuous Ops | 0.45 | 0.94 | 1.23 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 2.22 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $12,931,000 | $12,465,000 | $11,822,000 | $19,991,000 | $17,902,000 |